Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT03256045 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Terminated due to loss of funding and former PI left the institution

Conditions

Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

DRUG: Carfilzomib
OTHER: Chemosensitivity Assay
DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
DRUG: Panobinostat

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]